Back to Journals » Drug Design, Development and Therapy » Volume 9

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma

Total article views   Abstract views HTML views PDF downloads Totals
10,134 Dovepress* 6,728 1,068+ 1,705 7,796
PubMed Central* 0 2,338 660 2,338
Totals 6,728 3,406 2,365 10,134
*Since 23 March 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar